Crossmark

Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer

Crossref DOI link: https://doi.org/10.1007/s13402-022-00677-6

Published Online: 2022-05-11

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Dingxie https://orcid.org/0000-0002-8061-5704
Hofman, Paul
License Information

Text and Data Mining valid from 2022-05-11

Version of Record valid from 2022-05-11
More Information

Article History

Accepted: 20 April 2022

First Online: 11 May 2022

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Not applicable.

: There are no competing interests. The authors declare no potential conflicts of interest, except that Dingxie Liu has an equity interest in Bluewater Biotech LLC.

Document is current

Any future updates will be listed below